IRTC
$126.44
+$3.28 (2.66%)+2.66%
After HoursLoading chart...
IndexN/A
Market Cap4.16B
Enterprise Value6.17B
Income$-0.03B
Sales$0.16B
EmployeesN/A
P/E-197.56
P/S7.60
P/B37.18
P/C164.50
EV/EBITDA-1557.12
EV/SalesN/A
EPS (ttm)-0.64
EarningsN/A
Gross Margin70.57%
Oper. Margin-4.93%
Profit Margin-5.96%
Volume0.48M
Shs Outstand0.03B
Change2.66%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $591.84M | $492.68M | $410.92M | $322.82M | $265.17M | $214.55M | $147.28M | $99.13M |
| Cost of Revenue | $184.31M | $160.88M | $129.29M | $109.26M | $70.28M | $52.48M | $38.80M | $28.20M |
| Gross Profit | $407.53M | $331.81M | $281.63M | $213.57M | $194.89M | $162.07M | $108.48M | $70.93M |
| Gross Margin | 68.86% | 67.35% | 68.54% | 66.16% | 73.50% | 75.54% | 73.66% | 71.55% |
| Operating Expenses | $523.04M | $456.97M | $395.42M | $313.51M | $238.56M | $216.82M | $154.17M | $98.52M |
| Operating Income | $-115.50M | $-125.16M | $-113.78M | $-99.94M | $-43.67M | $-54.76M | $-45.69M | $-27.59M |
| Operating Margin | -19.52% | -25.40% | -27.69% | -30.96% | -16.47% | -25.52% | -31.02% | -27.83% |
| Net Income | $-113.29M | $-123.41M | $-116.16M | $-101.36M | $-43.83M | $-54.57M | $-50.38M | $-29.74M |
| Net Margin | -19.14% | -25.05% | -28.27% | -31.40% | -16.53% | -25.43% | -34.21% | -30.00% |
| EPS (Basic) | $-3.63 | $-4.04 | $-3.88 | $-3.46 | $-1.58 | $-2.16 | $-2.02 | $-1.30 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $931.45M | $433.14M | $448.22M | $462.97M | $511.74M | $306.21M | $119.71M | $133.12M |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $840.54M | $223.05M | $208.41M | $183.45M | $170.13M | $170.80M | $65.29M | $53.57M |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $90.91M | $210.10M | $239.81M | $279.51M | $341.61M | $135.41M | $54.42M | $79.55M |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $90.91M | $210.10M | $239.81M | $279.51M | $341.61M | $135.41M | $54.42M | $79.55M |
| Total Liabilities & Stockholders Equity | $931.45M | $433.14M | $448.22M | $462.97M | $511.74M | $306.21M | $119.71M | $133.12M |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Tangible Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $-113.29M | $-123.41M | $-116.16M | $-101.36M | $-43.83M | $-54.57M | $-50.38M | $-29.74M |
| Depreciation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $3.39M | $-50.10M | $-23.01M | $-37.75M | $-13.76M | $-21.86M | $-29.07M | $-14.91M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Latest news
iRhythm Investigates Cyber Incident After Hackers Claim Access To Sensitive DataBenzinga iRhythm Tech's Stock Selloff Went Too Far After Preliminary Update: AnalystBenzinga NEXGEL (NXGL) Q3 2025 Earnings Call TranscriptThe Motley Fool Global Cardiac Monitoring Devices Market to Cross USD 30 Billion by 2032, Driven by Telehealth and Remote Monitoring Trends | DelveInsightGlobeNewswire Inc. AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM ServiceGlobeNewswire Inc. Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the Motion to DismissGlobeNewswire Inc. Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032 | DelveInsightGlobeNewswire Inc. Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among AnalystsBenzinga
Show 12 more stories
Kaskela Law LLC Announces Shareholder Investigation of iRhythm Technologies, Inc. (NASDAQ: IRTC) and Encourages Long-Term IRTC Shareholders to Contact the FirmGlobeNewswire Inc. iRhythm Technologies Announces Results of GUARD-AF TrialGlobeNewswire Inc. Cannabis Concentrates Brands With Strong Growth: Acquisition Targets Amid Industry Consolidation - BenzingaBenzinga iRhythm Technologies executive sells $148k in stock By Investing.com - Investing.com CanadaInvesting.com iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing AutomationGlobeNewswire Inc. iRhythm Technologies to Present at the 2024 Truist Securities MedTech ConferenceGlobeNewswire Inc. iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock ConferenceGlobeNewswire Inc. The Analyst Landscape: 4 Takes On iRhythm TechnologiesBenzinga iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024GlobeNewswire Inc. iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?Zacks Investment Research iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional NotesGlobeNewswire Inc. iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029GlobeNewswire Inc.
Insider Trading
View AllInsider
Type
Shares
Price
Value
Date
Company
About the company
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
Discover more
You may be interested in